Melatonin pharmacokinetics in premenopausal and postmenopausal healthy female volunteers.
Markantonis
Sophia L
SL
Laboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, University of Athens, Panepistimiopolis, Athens 157.71, Greece.
Tsakalozou
Eleftheria
E
Paraskeva
Anteia
A
Staikou
Chryssoula
C
Fassoulaki
Argyro
A
D000284:Administration, Oral; D000328:Adult; D000367:Age Factors; D000704:Analysis of Variance; D019540:Area Under Curve; D015992:Body Mass Index; D002851:Chromatography, High Pressure Liquid; D004305:Dose-Response Relationship, Drug; D005260:Female; D006207:Half-Life; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008550:Melatonin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D008593:Menopause / Q000378:metabolism*; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D017697:Premenopause / Q000378:metabolism*; D012893:Sleep Wake Disorders / Q000139:chemically induced; D013997:Time Factors
D008550:Melatonin